Literature DB >> 27222079

Patients with chronic kidney disease have abnormal upper gastro-intestinal tract digestive function: A study of uremic enteropathy.

Claire J Grant1, Laura E Harrison2, Caroline L Hoad3, Luca Marciani4, Penny A Gowland3, Christopher W McIntyre1.   

Abstract

BACKGROUND AND AIM: Chronic kidney disease (CKD) affects gastrointestinal (GI) function and results in numerous adaptive and maladaptive responses. Disruption of the colonic microbiome and its attendant consequences-the loss of gut barrier integrity and increased generation of uremic toxins-has become well-recognized. However, less attention has been paid to characterizing the mechanisms behind dysfunction of the upper GI tract, largely owing to the difficulty of studying small bowel function in vivo. This present study was designed to comprehensively describe upper GI function in those with advanced renal impairment.
METHODS: Thirty-five non-diabetic subjects (12 CKD stage 4/5 patients, 23 healthy controls) underwent detailed GI magnetic resonance imaging (MRI) in both fasted and fed states. Upper GI function was assessed by quantification of gastric emptying and intra-luminal small bowel water. Characterization of hydration and cardiovascular status was performed at baseline. Gut barrier integrity was assessed using serum endotoxin level.
RESULTS: Chronic kidney disease was associated with dysmotility (gastric half-emptying time 96 ± 32 vs 74 ± 27 min, P = 0.04) and reduced fasting and post-prandial small bowel water (36 ± 22 mL vs 78 ± 42 mL, P < 0.001), reflecting abnormal digestive secretion, and absorption. This was related to the degree of endotoxemia (r = -0.60, P = 0.04) and poorer symptom scores, but not to disease severity, arterial stiffness or hydration status.
CONCLUSION: Chronic kidney disease adversely affects digestive function. Abnormalities in digestive secretion and absorption may potentially have a broad impact in the prevention and treatment of both CKD and its complications. Further study is required to assess the factors that contribute to this dysfunction in a wider CKD population.
© 2016 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  MRI; chronic kidney disease; gastrointestinal dysfunction; small bowel water

Mesh:

Substances:

Year:  2017        PMID: 27222079     DOI: 10.1111/jgh.13458

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  12 in total

1.  Indoxyl sulfate associates with cardiovascular phenotype in children with chronic kidney disease.

Authors:  Johannes Holle; Uwe Querfeld; Marietta Kirchner; Alexandros Anninos; Jürgen Okun; Daniela Thurn-Valsassina; Aysun Bayazit; Ana Niemirska; Nur Canpolat; Ipek Kaplan Bulut; Ali Duzova; Ali Anarat; Rukshana Shroff; Yelda Bilginer; Salim Caliskan; Cengiz Candan; Jerome Harambat; Zeynep Birsin Özcakar; Oguz Soylemezoglu; Sibylle Tschumi; Sandra Habbig; Ebru Yilmaz; Ayse Balat; Aleksandra Zurowska; Nilgun Cakar; Birgitta Kranz; Pelin Ertan; Anette Melk; Karolis Azukaitis; Franz Schaefer
Journal:  Pediatr Nephrol       Date:  2019-08-19       Impact factor: 3.714

Review 2.  Will MRI of gastrointestinal function parallel the clinical success of cine cardiac MRI?

Authors:  Caroline Hoad; Christopher Clarke; Luca Marciani; Martin John Graves; Maura Corsetti
Journal:  Br J Radiol       Date:  2018-10-24       Impact factor: 3.039

Review 3.  A systematic review on the efficacy and safety of PA21 versus sevelamer in dialysis patients.

Authors:  Dengpiao Xie; Naijing Ye; Mingquan Li
Journal:  Int Urol Nephrol       Date:  2018-01-02       Impact factor: 2.370

Review 4.  Phosphate Binders and Nonphosphate Effects in the Gastrointestinal Tract.

Authors:  Annabel Biruete; Kathleen M Hill Gallant; Stephen R Lindemann; Gretchen N Wiese; Neal X Chen; Sharon M Moe
Journal:  J Ren Nutr       Date:  2019-03-04       Impact factor: 3.655

5.  Gastrointestinal Microbiota in Patients with Chronic Kidney Disease: A Systematic Review.

Authors:  SeonYoon Chung; Jennifer L Barnes; Kim Schafer Astroth
Journal:  Adv Nutr       Date:  2019-09-01       Impact factor: 8.701

6.  Circulating Bacterial Fragments as Cardiovascular Risk Factors in CKD.

Authors:  Cheuk-Chun Szeto; Christopher William McIntyre; Philip Kam-Tao Li
Journal:  J Am Soc Nephrol       Date:  2018-04-17       Impact factor: 10.121

Review 7.  Gut Leakage of Fungal-Derived Inflammatory Mediators: Part of a Gut-Liver-Kidney Axis in Bacterial Sepsis.

Authors:  Panomwat Amornphimoltham; Peter S T Yuen; Robert A Star; Asada Leelahavanichkul
Journal:  Dig Dis Sci       Date:  2019-03-13       Impact factor: 3.199

8.  Gastrointestinal complications induced by sevelamer crystals.

Authors:  Claudia Yuste; Evangelina Mérida; Eduardo Hernández; Ana García-Santiago; Yolanda Rodríguez; Teresa Muñoz; Gonzalo Jesús Gómez; Ángel Sevillano; Manuel Praga
Journal:  Clin Kidney J       Date:  2017-04-10

9.  Capsule Endoscopy Transit Time to Duodenum: Relation to Patient Demographics.

Authors:  Alsadiq Al Hillan; Diana Curras-Martin; Michael Carson; Shreya Gor; Adaeze Ezeume; Varsha Gupta; Albino Copcaalvarez; Gagan Beri; Mordechai Bermann; Arif Asif
Journal:  Cureus       Date:  2020-02-05

Review 10.  Pharmacokinetics in children with chronic kidney disease.

Authors:  Anne M Schijvens; Saskia N de Wildt; Michiel F Schreuder
Journal:  Pediatr Nephrol       Date:  2019-08-02       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.